Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Modern Federal Threat Landscape
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
The Food and Drug Administration would have more power to catch tainted pharmaceuticals manufactured overseas before they enter the U.S. market under legislation passed Wednesday by House lawmakers.
Dr. Kyle Myers works with a team of physicists, engineers and mathematicians, who apply their expertise to evaluating imaging systems that help diagnosis medical conditions such as cancer.
On this week's show, host Allen Scott examines efforts to cut health care costs and their potential implications for businesses and federal and state budgets. Guests include Health Care Analysts Christopher Flavelle and Brian Rye, and Congressional Analyst Loren Duggan.
The Institute of Medicine said the Food and Drug Administration, Agriculture Department and other agencies should pony up some resources to batten down the hatches on imports.
The Department of Health and Human Services taps Frank Baitman to be its new chief information officer. He comes to HHS from the Food and Drug Administration where he was an entrepreneur-in-residence.
In a letter to Office of Management and Budget Acting Director Jeff Zients, the two lawmakers say the Food and Drug Administration lawsuit raises broader questions about how other agencies monitor employee use of personal email. The House and Senate members want OMB to conduct a governmentwide analysis of these policies.
The Food and Drug Administration takes too long to approve potentially life-saving treatments and devices, says the agency's former head.
Budget pressures could delay some of the General Services Administration's building projects — or scrap them altogether. Art Turowski, a senior vice president with the Government Investor Services group in Jones Lang LaSalle, joined In Depth with Francis Rose to discuss what the new spending numbers mean for the government's large-scale construction projects.
This month the National Institutes of Health created the new National Center for Advancing Translational Sciences (NCATS) to bridge the gap between scientific research and usable drugs or medical devices.
Peter Lurie, a senior advisor in the Office of the Commissioner at the FDA, told the Federal Drive with Tom Temin and Amy Morris the sooner the agency learns of an impending drug shortage the sooner it can take action.
Julian Pecquet, a staff writer for The Hill newspaper, joined the Federal Drive with Tom Temin and Amy Morris to discuss how a recent Executive Order affects the FDA's day-to-day business and more broadly how such orders affect agency operations.
President Barack Obama ordered the Food and Drug Administration on Monday to take new steps to send out early warnings about looming shortages and try to avert them.
After the Office of Special Counsel intervened on their behalf, two federal whistleblowers won a 45-day stay on personnel actions taken against them.
FDA's Bill Maisel, the deputy director for science and the chief scientist at the Center for Devices and Radiological Health joined the Federal Drive with Tom Temin and Amy Morris to discuss a planned network of outside experts.
The Food and Drug Administration has named Eric Perakslis as its new chief information officer and chief scientist for informatics.
The Office of Special Counsel is seeking to halt adverse personnel actions against two federal whistleblowers. Both employees were placed on unpaid administrative leave after they blew the whistle at their agencies.
The Food and Drug Administration wants the public to comment on eight draft proposals aimed at making the agency's enforcement data more "accessible and user-friendly," according to a release.
Sherri McGarry, a senior adviser with the Office of Foods at the FDA, joined the Federal Drive with Tom Temin and Amy Morris to discuss the new food-safety efforts at FDA.
The National Institutes of Health Director, Dr. Francis Collins, joined the Federal Drive with Tom Temin and Amy Morris to explain a partnership between the Defense Advanced Research Projects Agency, the National Institutes of Health and the Food and Drug Administration.